Clinical Trials
Showing 31-40 results of 49 total
Cancer|Women's Health
Investigational drug for treatment of Triple-Negative Breast Cancer
The purpose of this study is to evaluate the safety and effectiveness of investigational drug MK2870 in combination with other approved anti-cancer...
Cancer
New investigational drug for relapsed or refractory B-cell Non-Hodgkin Lymphoma.
This study will evaluate the safety and anti-cancer activity of Loncastuximab Tesirine in combination with other anti-cancer agents.
Cardiology and Vascular Diseases|Diabetes|Endocrinology|Obesity and Weight Management
REDEFINE 3, CagriSema in people living with obesity and cardiovascular diseases
The REDEFINE 3 study is evaluating the investigational use of the combination of cagrilinitide and semaglutide (CagriSema) compared to a placebo for use in...
Cardiology and Vascular Diseases|Diabetes|Endocrinology|Obesity and Weight Management
Investigational drug for cardiovascular and/or chronic kidney disease
This is a randomized, clinical trial to evaluate the safety and effectiveness of an investigational medicine, retatrutide, in patients with cardiovascular or...
Cardiology and Vascular Diseases|Diabetes|Endocrinology
Study for people who have or are at risk for heart disease, stroke, or PAD
This study is evaluating the safety and effectiveness of an investigation medicine for lowing Lipoproteint(a) in people who have or are at risk for heart...
Diabetes|Endocrinology
The AVANTI Study is comparing an investigational medicine to synthetic T4.
The purpose of the AVANTI Study is to evaluate if an investigational medicine is safe and effective in the treatment of primary hypothyroidism. The study...
Blood Disorders|Cancer
Study of REGN5458 plus Carfilzomib for multiple myeloma.
The primary purpose of this study is to assess the safety and tolerability an investigational drug, REGN5458, combined with the current approved standard of...
Blood Disorders|Cancer
A study for patients with aggressive B-cell non-Hodgkin lymphoma.
This study will evaluate the safety and tolerability of investigational drug IMPT-314. It will also help to determine the recommended phase 2 dosing.
Cardiology and Vascular Diseases
Investigational drug for pulmonary hypertension due to heart failure
The purpose of this Phase 2, double-blind, randomized trial is to evaluate the safety and effectiveness of investigational drug sotatercept compared to a...
Allergy, Asthma, Immunology|Ear, Nose and Throat Conditions|Lung Disorders|Otolaryngology|Pulmonary Medicine
Clinical Trial to study the effectiveness of Dupilumab on AERD
This study will look at the effect of dupilumab in blocking aspirin-induced reactions in patients diagnosed with Aspirin-Exacerbated Respiratory Disease...